Jefferies Maintains Hold on Oracle (ORCL) Post Q3; PT to $37
Get Alerts ORCL Hot Sheet
Price: $153.28 --0%
Rating Summary:
48 Buy, 21 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 9 | New: 8
Rating Summary:
48 Buy, 21 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 9 | New: 8
Join SI Premium – FREE
Jefferies analyst Ross MacMillan bumped current quarter estimates and his price target on Oracle (NASDAQ: ORCL) from $36 to $37, although their is no change to the firm's overall view and its Hold rating was maintained.
MacMillan comments, "ORCL's F3Q14 results were largely in line with expectations, with some puts ($0.02 currency devaluation impact) and takes (continued strong HW, lower than expected tax rate). While Cloud bookings improvement is positive, we still don't see anything in results/guidance that argues strongly for a change in our view at this point."
Q4 EPS goes from $0.93 to $0.94.
For an analyst ratings summary and ratings history on Oracle click here. For more ratings news on Oracle click here.
Shares of Oracle closed at $31.25 yesterday.
MacMillan comments, "ORCL's F3Q14 results were largely in line with expectations, with some puts ($0.02 currency devaluation impact) and takes (continued strong HW, lower than expected tax rate). While Cloud bookings improvement is positive, we still don't see anything in results/guidance that argues strongly for a change in our view at this point."
Q4 EPS goes from $0.93 to $0.94.
For an analyst ratings summary and ratings history on Oracle click here. For more ratings news on Oracle click here.
Shares of Oracle closed at $31.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BitGo Holdings (BTGO) PT Lowered to $10 at Rosenblatt
- Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share